Skip to main
AHCO

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth is a fast-growing company with a strong and diverse portfolio of products and services that are well-positioned to meet the increasing demand for in-home healthcare solutions. With a strong focus on value-based care and cost management, AdaptHealth is poised for continued growth and success in the future. Additionally, its expansion into connected healthcare and potential for future acquisitions provide further potential upside for the stock. The recent growth in their respiratory and diabetes segments, coupled with their active capitated pipeline, supports a positive outlook for this company.

Bears say

AdaptHealth is aggressively pursuing M&A opportunities to drive topline growth and strengthen its national footprint, while expanding its product offerings and leveraging its scalable platform for operating efficiency and margin expansion. The company's focus on sustainability and its home-based healthcare model provide appeal to investors, and its ongoing efforts to standardize operations and improve efficiency are driving consistent results. However, with limited organic earnings growth and some skepticism, AdaptHealth may face challenges in meeting its ambitious growth targets.

AdaptHealth Corp (AHCO) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 5 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.